在免疫学领域，CD8+T 细胞在抵抗病毒感染、癌症以及自身免疫疾病中扮演着至关重要的角色。因此，准确预测 T 细胞受体（TCR，T cell receptor）与主要组织相容性复合物（MHC，Major Histocompatibility ...

Hepatocellular carcinoma (HCC) stands as the dominant form of liver cancer, ranking as the fourth leading cause of ...

Hepatocellular carcinoma (HCC) stands as the dominant form of liver cancer, ranking as the fourth leading cause of cancer-related deaths globally ...

中国科学院分子细胞科学卓越创新中心（生物化学与细胞生物学研究所）许琛琦研究组联合上海科技大学王皞鹏研究组，在 Immunity 期刊发表了题为 Phase separation of chimeric antigen receptor ...

Financially, Immunocore has a strong cash position and stable revenue growth, but concerns remain about the pipeline's ...

11月27日，中南大学湘雅二医院血液内科彭宏凌教授团队在国际权威期刊Journal of Clinical Investigation（IF=19.4）发表了题为《IL-2-inducible T cell kinase deficiency sustains chimeric antigen receptor T cell therapy against tumor cells》的原创性研究论文 ...

The selection of this first target is a key step for the partnership between Medigene and WuXi Biologics, which aims to advance multiple TCR-TCEs over the next three years. The collaboration seeks to ...

Licensing agreement deal value for innovative T-cell receptor (TCR) immunotherapy drugs surged in 2024, with European ...

Medigene announces KRAS G12V as first target for TCR-guided T cell engagers: Planegg, Germany Tuesday, December 10, 2024, 17:00 Hrs [IST] Medigene AG, an oncology platform company ...

Paulina Velasquez, MD, assistant faculty member, St. Jude Children’s Research Hospital, discusses the differences between T-cell receptor (TCR)-based and chimeric antigen receptor (CAR) T-cell ...

Gil Blum, an analyst from Needham, reiterated the Buy rating on TScan Therapeutics (TCRX – Research Report). The associated price target ...